Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund ...

Masimo (NASDAQ:MASI) rose 3% after activist investor Politan Capital Management won two board seats after a bitter proxy ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.

The deal results in Masimo, a company specializing in medical-grade health monitoring devices, offering a “reference platform ...

In a report released on September 6, Vik Chopra from Wells Fargo maintained a Buy rating on Masimo (MASI – Research Report). The ...

Masimo CEO Joe Kiano later expressed concern that Apple may have been trying to steal the company’s blood oxygen sensor ...

Masimo has secured 510(k) clearance from the US Food and Drug Administration for its W1 medical watch for connectivity, enabling integration with the Masimo SafetyNet telemonitoring solution.

It seems that someone is stepping in to fill that gap. Masimo, a health technology company, has announced a new partnership with Google where the two companies will work together to build a new ...

Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from ...